Sintx Technologies SINT
NASDAQ SINT
$1.57 -0.02 (-1.26%)
At close: Aug 20, 2026 · 2:22 PM UTC

Sintx Technologies (SINT) Cash from Investing Activities (2013 - 2026)

Sintx Technologies (SINT) posted quarterly Cash from Investing Activities of -$7000.0 for Q1 2026, up 88.89% year-over-year from -$3705.9 in Q1 2025, and up 83.33% quarter-over-quarter from -$42000.0 in Q4 2025.

Sintx Technologies (SINT) Cash from Investing Activities (2013 - 2026) Analysis & Trends

Sintx Technologies' Cash from Investing Activities history runs 14 years deep, the most recent figure standing at -$7000.0 for Q1 2026.

  • In Q1 2026, Cash from Investing Activities rose 88.89% year-over-year to -$7000.0; the TTM figure through Mar 2026 stood at $969000.0 (up 1253.57% YoY), while the FY2025 annual figure was $913000.0, up 570.62% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at -$7000.0, up from -$42000.0 in the prior quarter.
  • The five-year high for Cash from Investing Activities was $666000.0 in Q3 2025, with the low at -$510000.0 in Q3 2022.
  • The 5-year median for Cash from Investing Activities is -$64000.0 (2022), against an average of -$55625.0.
  • Peak annual rise in Cash from Investing Activities reached 2248.39% in 2025, while the deepest fall reached 520.0% in 2025.
  • Sintx Technologies' Cash from Investing Activities stood at -$296000.0 in 2022, then jumped by 79.05% to -$62000.0 in 2023, then soared by 116.13% to $10000.0 in 2024, then plunged by 520.0% to -$42000.0 in 2025, then surged by 83.33% to -$7000.0 in 2026.
  • Business Quant data shows SINT's Cash from Investing Activities at -$7000.0 in Q1 2026, -$42000.0 in Q4 2025, and $666000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 199.63 Bn 194.02 Bn 7.27 Bn -673.00 Mn
2 Stryker 127.42 Bn 123.95 Bn 4.50 Bn -639.00 Mn
3 Medtronic 118.97 Bn 109.75 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 73.39 Bn 72.85 Bn 3.85 Bn -1.96 Bn
5 Edwards Lifesciences 51.97 Bn 47.72 Bn 1.35 Bn -193.20 Mn
6 Dexcom 34.32 Bn 32.37 Bn 830.00 Mn 329.80 Mn
7 GE HealthCare Technologies 33.76 Bn 31.65 Bn 2.18 Bn -115.00 Mn
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn -22.08 Mn
9 Steris 23.04 Bn 22.56 Bn 684.20 Mn -108.50 Mn
10 Sintx Technologies 7.61 Mn 7.61 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 -7,000.00
Mar 31, 2026 -7,000.00
Dec 31, 2025 -42,000.00
Dec 31, 2025 -42,000.00
Sep 30, 2025 666,000.00
Sep 30, 2025 666,000.00
Jun 30, 2025 352,000.00
Jun 30, 2025 352,000.00
Mar 31, 2025 -63,000.00
Mar 31, 2025 -63,000.00
Dec 31, 2024 10,000.00
Dec 31, 2024 10,000.00
Sep 30, 2024 -31,000.00
Sep 30, 2024 -31,000.00
Mar 31, 2024 -173,000.00
Mar 31, 2024 -173,000.00
Dec 31, 2023 -62,000.00
Dec 31, 2023 -62,000.00
Sep 30, 2023 -105,000.00
Sep 30, 2023 -105,000.00